Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 387

1.

HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.

Adams PC, Pankow JS, Barton JC, Acton RT, Leiendecker-Foster C, McLaren GD, Speechley M, Eckfeldt JH.

Circ Cardiovasc Genet. 2009 Feb;2(1):34-7. doi: 10.1161/CIRCGENETICS.108.813089. Epub 2009 Jan 23.

2.

Hemochromatosis and iron-overload screening in a racially diverse population.

Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P; Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators..

N Engl J Med. 2005 Apr 28;352(17):1769-78.

3.

HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.

Adams PC, McLaren CE, Speechley M, McLaren GD, Barton JC, Eckfeldt JH.

Can J Gastroenterol. 2013 Jul;27(7):390-2.

4.

Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.

McLaren CE, Barton JC, Gordeuk VR, Wu L, Adams PC, Reboussin DM, Speechley M, Chang H, Acton RT, Harris EL, Ruggiero AM, Castro O; Hemochromatosis and Iron Overload Screening Study Research Investigators..

Am J Hematol. 2007 Oct;82(10):898-905.

5.

Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.

Adams PC, Reboussin DM, Barton JC, Acton RT, Speechley M, Leiendecker-Foster C, Meenan R, Passmore L, McLaren CE, McLaren GD, Gordeuk V, Dawkins F, Eckfeldt JH.

Int J Lab Hematol. 2008 Aug;30(4):300-5. doi: 10.1111/j.1751-553X.2007.00956.x.

PMID:
18665827
6.

Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.

Gottschalk R, Seidl C, Schilling S, Braner A, Seifried E, Hoelzer D, Kaltwasser JP.

Eur J Immunogenet. 2000 Jun;27(3):129-34.

PMID:
10940080
7.

Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study.

Acton RT, Barton JC, Passmore LV, Adams PC, Speechley MR, Dawkins FW, Sholinsky P, Reboussin DM, McLaren GD, Harris EL, Bent TC, Vogt TM, Castro O.

Diabetes Care. 2006 Sep;29(9):2084-9.

PMID:
16936157
8.

Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.

Barton JC, Acton RT, Dawkins FW, Adams PC, Lovato L, Leiendecker-Foster C, McLaren CE, Reboussin DM, Speechley MR, Gordeuk VR, McLaren GD, Sholinsky P, Harris EL.

Genet Test. 2005 Fall;9(3):231-41.

PMID:
16225403
10.

HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.

Pankow JS, Boerwinkle E, Adams PC, Guallar E, Leiendecker-Foster C, Rogowski J, Eckfeldt JH.

Transl Res. 2008 Jul;152(1):3-10. doi: 10.1016/j.trsl.2008.05.005. Epub 2008 Jun 13.

11.

HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.

Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, McLaren GD, Eckfeldt JH, McLaren CE, Reboussin DM, Gordeuk VR, Speechley MR, Reiss JA, Press RD, Dawkins FW; Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators..

Genet Test. 2007 Fall;11(3):269-75.

PMID:
17949288
12.

[Molecular genetic diagnostics and screening of hereditary hemochromatosis].

Zlocha J, Kovács L, Pozgayová S, Kupcová V, Durínová S.

Vnitr Lek. 2006 Jun;52(6):602-8. Slovak.

PMID:
16871764
13.

Iron-overload-related disease in HFE hereditary hemochromatosis.

Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM.

N Engl J Med. 2008 Jan 17;358(3):221-30. doi: 10.1056/NEJMoa073286.

14.

Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.

Adams PC, Speechley M, Barton JC, McLaren CE, McLaren GD, Eckfeldt JH.

Hepatology. 2012 Jun;55(6):1722-6. doi: 10.1002/hep.25538. Epub 2012 Apr 18.

15.

Hemochromatosis mutations in the general population: iron overload progression rate.

Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG.

Blood. 2004 Apr 15;103(8):2914-9. Epub 2003 Dec 4.

17.

Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and whites in the Hemochromatosis and Iron Overload Screening Study.

Barton JC, Acton RT, Lovato L, Speechley MR, McLaren CE, Harris EL, Reboussin DM, Adams PC, Dawkins FW, Gordeuk VR, Walker AP; Hemochromatosis and Iron Overload Screening Study Research Investigators..

Clin Genet. 2006 Jan;69(1):48-57.

18.

Significance of H63D homozygosity in a Basque population with hemochromatosis.

Castiella A, Zapata E, de Juan MD, Otazua P, Fernandez J, Zubiaurre L, Arriola JA; Gipuzkoa Hemochromatosis Group..

J Gastroenterol Hepatol. 2010 Jul;25(7):1295-8. doi: 10.1111/j.1440-1746.2010.06247.x.

PMID:
20594259
19.

A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.

Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK.

Gastroenterology. 2002 Mar;122(3):646-51. Erratum in: Gastroenterology 2002 Apr;122(4):1191.

PMID:
11874997
20.

Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.

Ryan E, Ryan JD, Russell J, Coughlan B, Tjalsma H, Swinkels DW, Stewart S, Crowe JP.

Acta Haematol. 2015;133(2):155-61. doi: 10.1159/000363490. Epub 2014 Sep 26.

PMID:
25277871

Supplemental Content

Support Center